Company performance
Current Price
as of Jan 07, 2025$1.86
P/E Ratio
N/A
Market Cap
$58.94M
- DHC
Description
Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Chicago, IL.
Metrics
Overview
- HQChicago, IL
- SectorHealth Technology
- IndustryMedical Specialties
- TickerTLIS
- Price$1.86+3.91%
Trading Information
- Market cap$58.94M
- Float5.28%
- Average Daily Volume (1m)3,753
- Average Daily Volume (3m)4,460
- EPS-$28.02
Company
- Revenue$0.30M
- Rev growth (1yr)-100.00%
- Net income-$8.85M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$8.49M
- EV-$25.28M
- EV/Revenue-84.26
- P/EN/A
- P/S11.30
- P/B1.21
Documents
SEC Filings